AFG
DXCM icon

Albion Financial Group’s DexCom DXCM Stock Holding History

Albion Financial Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19
Closed -$2.15K – 517
2024
Q2 		$2.15K Hold
19
– – ﹤0.01% 426
2024
Q1 		$2.64K Buy
+19
New +$2.39K ﹤0.01% 400
2023
Q3 		– Sell
-1
Closed -$129 – 486
2023
Q2 		$129 Buy
+1
New +$121 ﹤0.01% 460
2022
Q3 		– Sell
-40
Closed -$3K – 467
2022
Q2 		$3K Hold
40
– – ﹤0.01% 383
2022
Q1 		$5K Sell
40
-40
-50% -$4.38K ﹤0.01% 408
2021
Q4 		$11K Buy
+80
New +$11.5K ﹤0.01% 399

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Albion Financial Group's DXCM Position: Q3 2024 in Review

Albion Financial Group sold out of DexCom (DXCM) in Q3 2024, closing a stake of 19 shares — an estimated $2.15K sold.

Albion Financial Group first reported a position in DXCM in Q4 2021 and held it in 6 quarters. The position peaked at $11K in Q4 2021. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Albion Financial Group reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Albion Financial Group sold 19 DexCom shares in Q3 2024, an estimated $2.15K.
  • Albion Financial Group first reported a position in DexCom in Q4 2021 and held it in 6 quarters.
  • Albion Financial Group's DexCom position peaked at $11K in Q4 2021.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Albion Financial Group's 13F filing for Q3 2024, filed 9 Oct 2024.